ARVO
Did you meet us in the Association for Research in Vision and Ophthalmology (ARVO), 7-11 May 2017 in Baltimore? Would you like […]
Microbiology commitment
Synovo’s presence in the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Better Use of Antibiotics Prize
Synovo GmbH and Qualizyme diagnostics collaboration: Finalists for the Better Use of Antibiotics Prize An innovative detection system for airway infections developed […]
Vision
The European-funded project VISION has come to an end, but enormous achievements have been made and this is not the end but […]
Folsmart kick-off meeting
The FOLSMART Kick-off meeting took place in Brussels last week. FOLSMART, Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis, granted by the […]
Synovo and ophthalmology
We expand business to ophthalmologyTübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic […]
Orphan designation for pancreatic cancer
Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by […]